[1] |
REN Yuke, QU Zhe, LAI Zixuan, ZHANG Di, ZHAO Yongtian, YANG Yanwei, LI Shuangxing, HUO Guitao, ZHOU Xiaobing, LIN Zhi, GENG Xingchao.
Pharmacodynamic Evaluation of CAR-T Cell Products Based on Deep Learning Convolutional Neural Network Recognition
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 742-748.
|
[2] |
LI Dong, SONG Yana, WANG Ligang, BIAN Rongrong, ZHAO Yan.
Considerations for Establishing National Sentinel Hospitals for Medical Device Adverse Event Monitoring
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 780-785.
|
[3] |
WANG Tao, SONG Haibo, WANG Qing, HOU Yongfang, LIU Hongliang, ZHANG Lin.
Brief introduction and inspiration to the WHO guidance on Ethics and Governance of Artificial Intelligence for Health
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 906-909.
|
[4] |
JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling.
Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166.
|
[5] |
ZHANG Qi, CHEN Min, ZHANG Shiqing.
Conditional approval of medical devices in the United States and enlightenment
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1007-1010.
|
[6] |
WANG Tao, ZHENG Mingjie, LIU Hongliang, WANG Qing, SHEN Chuanyong.
Current applications of artificial intelligence in pharmacovigilance in the USA and implications
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1129-1133.
|
[7] |
ZHENG Chao, WU Yan, ZHANG Lan, HU Kai, ZENG Ye, WANG Wen, WANG Ling.
Methods for risk trend analysis of EU post-marketing surveillance for medical devices
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(1): 79-82.
|
[8] |
TAN Jing, LIU Chunrong, HUANG Shiyao, GAO Pei, WANG Yang, LI Chen, HE Yong, YUAN Hong, WANG Wen, LI Ling, XIONG Yiquan, REN Yan, YAO Minghong, ZHAO Yan, DONG Fang, SHEN Chuanyong, SUN Xin.
Expert consensus on post-marketing risk monitoring technology for high-risk implantable passive medical devices based on real world data
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(1): 13-17.
|
[9] |
MAO Zhenbin, LIU Shuyu.
Implications of Regulatory Science for the Construction of Medical Device Vigilance Systems
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(7): 601-605.
|
[10] |
JU Shan, LIU Yinghui, WANG Yawen, TENG Yingying, JIANG Yan, DENG Gang, SUN Lei.
Clinical Evaluation of Medical Devices Seen from International Coordination Documents
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(11): 1062-1065.
|
[11] |
SONG Meihua, ZHANG Tingyu, GE Ziruo, XU Yanli, CHEN Zhihai, QIAN Fang.
Efficacy of Human COVID-19 Immunoglobulin (pH4) for Intravenous Injection against COVID-19
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(10): 905-909.
|
[12] |
CHEN Feng.
Latest Development of International Pharmacovigilance and Its Implications
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(12): 867-870.
|
[13] |
LIN Ni, JIN Hong-tao, WANG Ai-ping.
Progress in Safety Evaluation and Usage of Plasticizers in Medical Devices
[J]. Chinese Journal of Pharmacovigilance, 2014, 11(2): 100-103.
|
[14] |
Li Yu-ji ,SHI Yu-qing .
Analysis of Adverse Event Reports of Surgicel in MAUDE Database
[J]. Chinese Journal of Pharmacovigilance, 2013, 10(5): 312-314.
|
[15] |
KONG Xiang -hong ,ZHANG Wei –hua, YAN Ting –ting.
Analysis of 1059 Suspected Medical Device Adverse Event Reports
[J]. Chinese Journal of Pharmacovigilance, 2013, 10(4): 232-234.
|